Literature DB >> 16167177

Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release.

A M Aleardi1, G Benard, O Augereau, M Malgat, J C Talbot, J P Mazat, T Letellier, J Dachary-Prigent, G C Solaini, R Rossignol.   

Abstract

Intracellular amyloid beta-peptide (A beta) accumulation is considered to be a key pathogenic factor in sporadic Alzheimer's disease (AD), but the mechanisms by which it triggers neuronal dysfunction remain unclear. We hypothesized that gradual mitochondrial dysfunction could play a central role in both initiation and progression of sporadic AD. Thus, we analyzed changes in mitochondrial structure and function following direct exposure to increasing concentrations of A beta(1--42) and A beta(25--35) in order to look more closely at the relationships between mitochondrial membrane viscosity, ATP synthesis, ROS production, and cytochrome c release. Our results show the accumulation of monomeric A beta within rat brain and muscle mitochondria. Subsequently, we observed four different and additive modes of action of A beta, which were concentration dependent: (i) an increase in mitochondrial membrane viscosity with a concomitant decrease in ATP/O, (ii) respiratory chain complexes inhibition, (iii) a potentialization of ROS production, and (iv) cytochrome c release.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167177     DOI: 10.1007/s10863-005-6631-3

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  72 in total

Review 1.  Genotypes and clinical phenotypes in children with cytochrome-c oxidase deficiency.

Authors:  N Darin; A-R Moslemi; S Lebon; P Rustin; E Holme; A Oldfors; M Tulinius
Journal:  Neuropediatrics       Date:  2003-12       Impact factor: 1.947

2.  Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

Authors:  O Wirths; G Multhaup; C Czech; V Blanchard; S Moussaoui; G Tremp; L Pradier; K Beyreuther; T A Bayer
Journal:  Neurosci Lett       Date:  2001-06-22       Impact factor: 3.046

3.  beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria.

Authors:  L Canevari; J B Clark; T E Bates
Journal:  FEBS Lett       Date:  1999-08-20       Impact factor: 4.124

4.  Cytochrome c oxidase is decreased in Alzheimer's disease platelets.

Authors:  Sandra Morais Cardoso; M Teresa Proença; Sancha Santos; Isabel Santana; Catarina R Oliveira
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

5.  Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure.

Authors:  Paula I Moreira; Maria S Santos; António M Moreno; Raquel Seiça; Catarina R Oliveira
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

6.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

Authors:  Alexander V Panov; Claire-Anne Gutekunst; Blair R Leavitt; Michael R Hayden; James R Burke; Warren J Strittmatter; J Timothy Greenamyre
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

7.  Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.

Authors:  M F Knauer; B Soreghan; D Burdick; J Kosmoski; C G Glabe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 8.  Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress.

Authors:  Laura Canevari; Andrey Y Abramov; Michael R Duchen
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

9.  Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease.

Authors:  P Fernández-Vizarra; A P Fernández; S Castro-Blanco; J Serrano; M L Bentura; R Martínez-Murillo; A Martínez; J Rodrigo
Journal:  Histol Histopathol       Date:  2004-07       Impact factor: 2.303

10.  Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease.

Authors:  Michelangelo Mancuso; Massimiliano Filosto; Francesca Bosetti; Roberto Ceravolo; Anna Rocchi; Gloria Tognoni; Maria Laura Manca; Giancarlo Solaini; Gabriele Siciliano; Luigi Murri
Journal:  Exp Neurol       Date:  2003-08       Impact factor: 5.330

View more
  60 in total

1.  Hyperoxia fully protects mitochondria of explanted livers.

Authors:  G Sgarbi; F Giannone; G A Casalena; A Baracca; M Baldassare; P Longobardi; P Caraceni; M Derenzini; G Lenaz; D Trerè; Giancarlo Solaini
Journal:  J Bioenerg Biomembr       Date:  2011-10-21       Impact factor: 2.945

2.  Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease.

Authors:  R Derungs; G G Camici; R D Spescha; T Welt; C Tackenberg; C Späni; F Wirth; A Grimm; A Eckert; R M Nitsch; L Kulic
Journal:  Mol Psychiatry       Date:  2016-07-19       Impact factor: 15.992

3.  Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.

Authors:  P Hemachandra Reddy; Maria Manczak; XiangLing Yin
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Caspase-independent mitochondrial cell death results from loss of respiration, not cytotoxic protein release.

Authors:  Lydia Lartigue; Yulia Kushnareva; Youngmo Seong; Helen Lin; Benjamin Faustin; Donald D Newmeyer
Journal:  Mol Biol Cell       Date:  2009-09-30       Impact factor: 4.138

5.  Monitoring of the decreased mitochondrial viscosity during heat stroke with a mitochondrial AIE probe.

Authors:  Yuewei Zhang; Shuohang Wang; Xiaodong Wang; Qi Zan; Xue Yu; Li Fan; Chuan Dong
Journal:  Anal Bioanal Chem       Date:  2021-05-02       Impact factor: 4.142

Review 6.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

7.  A new link to mitochondrial impairment in tauopathies.

Authors:  Kathrin L Schulz; Anne Eckert; Virginie Rhein; Sören Mai; Winfried Haase; Andreas S Reichert; Marina Jendrach; Walter E Müller; Kristina Leuner
Journal:  Mol Neurobiol       Date:  2012-07-31       Impact factor: 5.590

Review 8.  Convergence of amyloid-beta and tau pathologies on mitochondria in vivo.

Authors:  Anne Eckert; Kathrin L Schulz; Virginie Rhein; Jürgen Götz
Journal:  Mol Neurobiol       Date:  2010-03-09       Impact factor: 5.590

9.  Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam.

Authors:  Kristina Leuner; Christopher Kurz; Giorgio Guidetti; Jean-Marc Orgogozo; Walter E Müller
Journal:  Front Neurosci       Date:  2010-09-07       Impact factor: 4.677

10.  Mitochondrial complex III defects contribute to inefficient respiration and ATP synthesis in the myocardium of Trypanosoma cruzi-infected mice.

Authors:  Jian-Jun Wen; Nisha Jain Garg
Journal:  Antioxid Redox Signal       Date:  2010-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.